The Impact Of Art On Wellbeing In Autoimmune Disease PDF Print E-mail
Tuesday, 25 October 2011 09:11
taken from http://www.flickr.com/photos/georgiap/2230846846/ via creative commonsAn innovative Newcastle research project is measuring the impact of creating art on the symptoms and overall wellbeing of people living with an autoimmune illness.

A team at the University of Newcastle, in conjunction with the Autoimmune Resource and Research Centre at John Hunter Hospital, is working with participants with a range of autoimmune illnesses including Lupus, Scleroderma, Rheumatoid Arthritis and Sjögren's syndrome. Dr Kathryn Grushka from the University said the team was monitoring improvements to participants’ sense of wellbeing and measureable indicators of health, particularly levels of stress.

“Stress is a major flare factor for autoimmune illnesses. We are testing levels of the stress hormone cortisol by taking saliva samples before and after artmaking workshops,” Dr Grushka said.

Participants’ quality of life and functionality is being measured by reviewing digital and written diaries and through standard health assessments, such as testing mobility, blood pressure and heart rate.

The study consists of artists, non-artists and those without an autoimmune illness, with all participants asked to produce artworks based on personal experiences. The results are due to be published in early 2012.

Work created through the project will be displayed in the halls of John Hunter Hospital from Tuesday 4 October, Lupus awareness month, until January 2012 as part of Hunter New England Health’s ‘Arts for Health Program’.

 
More articles :

» Two Problems That People With Scleroderma Face: Malabsorption and Inflammation

According to , many doctors agree that starts with inflammation, and its progress depends on how much inflammation continues to occur in the body. That's one reason some doctors recommend that patients with any sort of inflammatory disease such as...

» Active Biotech Presents Data regarding the 57-57 Project at EULAR

Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data from an exploratory clinical trial in Systemic Lupus Erythematosus (SLE) patients at the Annual European Congress of Rheumatology EULAR 2011, an international event for specialists in the...

» Tips for Working Out in the Heat

You have been loyal to your outdoor exercise program for months; walking, even when your muscles ached or biking, even when your arthritis acted up. Due to your dedication, your body is strong, your health is good and your endurance is better than...

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» Analytical Chemistry Used In Systemic Sclerosis Study

Scientists have used methods to identify new target autoantigens in patients with systemic sclerosis (SSc).The study, published by , stated that antinuclear antibodies (ANA) can normally be found in 90 per cent of SSc patients with the use of...

» The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis

Theresa C. Barnes,Marina E. Anderson, and Robert J.MootsReceived 1 June 2011; Accepted 21 July 2011Systemic sclerosis (SSc) is a connective tissue disease characterised by fibrosis, vasculopathy, and immunological abnormalities. Over recent years,...